In treatment of Parkinsonism, L–Dopa is combined with carbidopa mainly :
To decrease dose requirement of L–Dopa
To decrease side effects of L–Dopa
To decrease effectiveness of L–Dopa
To increase crossing of L–Dopa through BBB